Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Factor Xa inhibitors prepared at DuPont Merck

Nov. 4, 1997

New orally active thrombin inhibitors from Merck & Co.

Nov. 3, 1997

Ortho discloses peptide serine protease inhibitors

Oct. 30, 1997

Advisory committee recommends approval for Plavix

Oct. 29, 1997

New serine protease inhibitors for thrombotic disorders from Akzo Nobel

Oct. 29, 1997

Factor Xa inhibitors from Zeneca for use as anticoagulants/antithrombotics

Oct. 27, 1997

Patents issued to Corvas for serine protease inhibitors

Oct. 22, 1997

Gensia receives FDA approval for desmopressin acetate injection

Oct. 21, 1997

Two large trials support use of alteplase accelerated infusion for acute MI

Oct. 20, 1997

Staphylokinase vs. alteplase for thrombolysis in rabbit stroke model

Oct. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...